OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SRSN$70.0056

Indo Acidatama Tbk PT

Diversified ChemicalsVerified

Indo Acidatama Tbk PT maintains a conservative capital structure, with a debt-to-equity ratio of 0.14 and a current ratio of 2.93, indicating strong short-term liquidity. However, the company reports negative net cash after subtracting total debt, signaling potential liquidity constraints despite its low leverage. The price-to-book ratio of 0.52 suggests the market values the company below its book value, while the price-to-earnings ratio of 5.45 reflects a low valuation relative to earnings. Profitability metrics show a return on equity (ROE) of 9.55% and return on assets (ROA) of 7.35%, both below the typical thresholds for high-margin chemical producers. Gross profit of IDR 312.1 billion and operating income of IDR 122.1 billion represent 24.8% and 9.7% of revenue, respectively, indicating moderate efficiency in cost control and operational leverage. The company’s revenue is concentrated across three segments: Ethanol, Acetic Acid, and Others. While the Ethanol and Acetic Acid segments are core to its operations, the "Others" category likely includes agro-input products such as biofertilizers and soil conditioners. No geographic breakdown is provided, but the company operates primarily in Indonesia, exposing it to local demand and regulatory risks. Outlook data is not provided for future revenue or earnings, but historical revenue of IDR 1.26 trillion and operating cash flow of IDR 255.8 billion suggest stable cash generation. The company’s capital expenditure of IDR 35.0 billion in the latest period indicates ongoing investment in production capacity or maintenance. Risk factors include medium liquidity risk due to negative net cash and low dilution risk, as shares outstanding remain unchanged between basic and diluted measures. No recent equity issuance or dilutive events are reported, and the company has not disclosed material dilution risks in its filings. No recent events such as earnings calls, regulatory actions, or major business developments are disclosed in the provided data. The company’s operations appear to be in a steady state, with no immediate catalysts or disruptions flagged.

30-day price · SRSN+8.00 (+12.5%)
Low$58.00High$83.00Close$72.00As of17 May, 00:00 UTC
Profile
CompanyIndo Acidatama Tbk PT
TickerSRSN.JK
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryDiversified Chemicals
AI analysis

Business. Indo Acidatama Tbk PT produces ethanol, acetic acid, and ethyl acetate for industrial and agro-chemical applications, generating revenue through sales of chemical and agro-input products.

Classification. The company is classified under Diversified Chemicals (Basic Materials sector) with 92% confidence, aligning with its production of ethanol, acetic acid, and related derivatives.

Indo Acidatama Tbk PT maintains a conservative capital structure, with a debt-to-equity ratio of 0.14 and a current ratio of 2.93, indicating strong short-term liquidity. However, the company reports negative net cash after subtracting total debt, signaling potential liquidity constraints despite its low leverage. The price-to-book ratio of 0.52 suggests the market values the company below its book value, while the price-to-earnings ratio of 5.45 reflects a low valuation relative to earnings. Profitability metrics show a return on equity (ROE) of 9.55% and return on assets (ROA) of 7.35%, both below the typical thresholds for high-margin chemical producers. Gross profit of IDR 312.1 billion and operating income of IDR 122.1 billion represent 24.8% and 9.7% of revenue, respectively, indicating moderate efficiency in cost control and operational leverage. The company’s revenue is concentrated across three segments: Ethanol, Acetic Acid, and Others. While the Ethanol and Acetic Acid segments are core to its operations, the "Others" category likely includes agro-input products such as biofertilizers and soil conditioners. No geographic breakdown is provided, but the company operates primarily in Indonesia, exposing it to local demand and regulatory risks. Outlook data is not provided for future revenue or earnings, but historical revenue of IDR 1.26 trillion and operating cash flow of IDR 255.8 billion suggest stable cash generation. The company’s capital expenditure of IDR 35.0 billion in the latest period indicates ongoing investment in production capacity or maintenance. Risk factors include medium liquidity risk due to negative net cash and low dilution risk, as shares outstanding remain unchanged between basic and diluted measures. No recent equity issuance or dilutive events are reported, and the company has not disclosed material dilution risks in its filings. No recent events such as earnings calls, regulatory actions, or major business developments are disclosed in the provided data. The company’s operations appear to be in a steady state, with no immediate catalysts or disruptions flagged.
Key takeaways
  • The company maintains a low debt-to-equity ratio (0.14) and strong current ratio (2.93), but reports negative net cash after debt, signaling potential liquidity constraints.
  • ROE of 9.55% and ROA of 7.35% indicate moderate profitability, with gross and operating margins at 24.8% and 9.7% of revenue, respectively.
  • Revenue is concentrated in three segments, with no geographic diversification reported, exposing the company to local market risks.
  • Capital expenditure of IDR 35.0 billion suggests ongoing investment in production, but no future growth guidance is provided.
  • Low dilution risk is supported by unchanged shares outstanding and no disclosed dilutive events.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyIDR
Revenue$1.26T
Gross profit$312.08B
Operating income$122.09B
Net income$77.35B
R&D
SG&A
D&A
SBC
Operating cash flow$255.84B
CapEx-$35.02B
Free cash flow$56.04B
Total assets$1.05T
Total liabilities$242.59B
Total equity$809.82B
Cash & equivalents
Long-term debt$109.93B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$70.00
Market cap$421.40B
Enterprise value$531.33B
P/E5.5
Reported non-GAAP P/E
EV/Revenue0.4
EV/Op income4.3
EV/OCF2.1
P/B0.5
P/Tangible book0.5
Tangible book$809.82B
Net cash-$109.93B
Current ratio2.9
Debt/Equity0.1
ROA7.3%
ROE9.6%
Cash conversion3.3%
CapEx/Revenue-2.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Diversified Chemicals · cohort 80 companies
MetricSRSNActivity
Op margin9.7%-1.1% medp25 -1.1% · p75 -1.1%top quartile
Net margin6.2%-6.6% medp25 -6.6% · p75 -6.6%top quartile
Gross margin24.8%12.9% medp25 12.9% · p75 12.9%top quartile
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-2.8%-7.1% medp25 -12.7% · p75 -4.4%top quartile
Debt / equity14.0%1639.6% medp25 1639.6% · p75 1639.6%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-03 22:48 UTC#a466bb0d
Market quoteclose IDR 70.00 · shares 6.02B diluted
no public URL
2026-05-03 22:48 UTC#88b2b58f
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 22:49 UTCJob: 616695ef